I think if we can hold low 1.20's until next week or so and hardly anyone applies for their rights and pincus gets 30-40% of the co this will be one of the turnaround stories of the year.
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress